ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623660; 2) Community: the network communities that were significantly associated with the response to NSC 623660; 3) Molecule: the relationships between components within communities and NSC 623660; 4) MDR: the compounds that were significantly associated with the NSC 623660.

NSC Compound Enrichment Correlation
NSC 691895 Null 0.0467178916101842 0.51502166
NSC 696923 Null 0.0467178916101842 -0.14417299
NSC 700269 1,3-Dioxolo[4,5-g]quinolin-8(5H)-thione, 6-(2-fluorophenyl)- 0.0467178916101842 -0.064266358
NSC 701812 11H-Indeno[1,2-c]isoquinolinium,2,3-dimethoxy-8,9-(methylenedioxy)-6-propyl-, chloride 0.0467178916101842 0.10903661
NSC 713324 Null 0.0467178916101842 0.10646811
NSC 720340 Null 0.0467178916101842 0.1706512
NSC 724910 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10,10'-[(2-hydroxy-1,3-propanediyl)bis(oxy)] bis[decahydro- 3,6,9-trimethyl-, hemisuccinate 0.0467178916101842 0.23883159
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0467178916101842 0.28050974
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0467178916101842 0.011627347
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0467178916101842 0.21601208
Total:85  Current:83    [First] [Prev] [Next] [Last]